The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Langerhans-Cell Histiocytosis
Open accessAbstract
A spectrum of diseases formerly known as histiocytosis X and now called Langerhans-cell histiocytosis is characterized by ERK pathway activation (including BRAF V600E mutations) and diverse clinical manifestations involving bone, skin, lung, and pituitary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,424
Acute Lymphoblastic Leukemia in Children
Hunger, S. P., & Mullighan, C. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1400972 · Cited by 2,204
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
Hyman, D. M., Puzanov, I., Subbiah, V., Faris, J. E., Chau, I., Blay, J.-Y., Wolf, J., Raje, N. S., Diamond, E. L., Hollebecque, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502309 · Cited by 1,764
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Emile, J.-F., Abla, O., Fraitag, S., Horne, A., Haroche, J., Donadieu, J., Requena-Caballero, L., Jordan, M. B., Abdel-Wahab, O., Allen, C. E., et al. (2016) · Blood · doi:10.1182/blood-2016-01-690636 · Cited by 1,591
Self-citationERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence
Cagnol, S., & Chambard, J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07366.x · Cited by 1,290
Recurrent BRAF mutations in Langerhans cell histiocytosis
Badalian-Very, G., Vergilio, J.-A., Degar, B. A., MacConaill, L. E., Brandner, B., Calicchio, M. L., Kuo, F. C., Ligon, A. H., Stevenson, K. E., Kehoe, S. M., et al. (2010) · Blood · doi:10.1182/blood-2010-04-279083 · Cited by 1,243
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions
Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T., Henning, G., & Förster, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.014 · Cited by 1,086
Langerhans'-Cell Histiocytosis (Histiocytosis X) -- A Clonal Proliferative Disease
Willman, C. L., Busque, L., Griffith, B. B., Favara, B. E., McClain, K. L., Duncan, M. H., & Gilliland, D. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407213310303 · Cited by 994
Self-citationLangerhans cells renew in the skin throughout life under steady-state conditions
Merad, M., Manz, M. G., Karsunky, H., Wagers, A., Peters, W., Charo, I., Weissman, I. L., Cyster, J. G., & Engleman, E. G. (2002) · Nature Immunology · doi:10.1038/ni852 · Cited by 977
Self-citationValladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80160-0 · Cited by 962
Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells
Merad, M., Ginhoux, F., & Collin, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2455 · Cited by 850
Contemporary classification of histiocytic disorders
Favara, B. E., Feller, A. C., Pauli, M., Jaffe, E. S., Weiss, L. M., Arico, M., Bucsky, P., Egeler, R. M., Elinder, G., Gadner, H., et al. (1997) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199709)29:3<157::aid-mpo1>3.0.co;2-c · Cited by 837
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.2.380 · Cited by 814
Hoeffel, G., Wang, Y., Greter, M., See, P., Teo, P., Malleret, B., Leboeuf, M., Low, D., Oller, G., Almeida, F., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120340 · Cited by 786
Self-citationLangerhans cells arise from monocytes in vivo
Ginhoux, F., Tacke, F., Angeli, V., Bogunovic, M., Loubeau, M., Dai, X.-M., Stanley, E. R., Randolph, G. J., & Merad, M. (2006) · Nature Immunology · doi:10.1038/ni1307 · Cited by 738
Self-citationUeber die Nerven der menschlichen Haut
Langerhans, P. (1868) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01959006 · Cited by 697
Pileri, S. A., Grogan, T. M., Harris, N. L., Banks, P., Campo, E., Chan, J. K. C., Favera, R. D., Delsol, G., De Wolf‐Peeters, C., Falini, B., et al. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01418.x · Cited by 665
Haroche, J., Cohen-Aubart, F., Emile, J.-F., Arnaud, L., Maksud, P., Charlotte, F., Cluzel, P., Drier, A., Hervier, B., Benameur, N., et al. (2013) · Blood · doi:10.1182/blood-2012-07-446286 · Cited by 537
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Diamond, E. L., Durham, B. H., Haroche, J., Yao, Z., Ma, J., Parikh, S. A., Wang, Z., Choi, J., Kim, E., Cohen-Aubart, F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0913 · Cited by 535
Berres, M.-L., Lim, K. P. H., Peters, T., Price, J., Takizawa, H., Salmon, H., Idoyaga, J., Ruzo, A., Lupo, P. J., Hicks, M. J., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130977 · Cited by 442
Self-citationChakraborty, R., Hampton, O. A., Shen, X., Simko, S. J., Shih, A., Abhyankar, H., Lim, K. P. H., Covington, K. R., Trevino, L., Dewal, N., et al. (2014) · Blood · doi:10.1182/blood-2014-05-577825 · Cited by 431
Self-citationDiamond, E. L., Subbiah, V., Lockhart, A. C., Blay, J.-Y., Puzanov, I., Chau, I., Raje, N. S., Wolf, J., Erinjeri, J. P., Torrisi, J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5029 · Cited by 413
Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis
Yu, R. C., Chu, A. C., Chu, C., & Buluwela, L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91842-2 · Cited by 388
High prevalence of somatic MAP2K1 mutations in BRAF V600E–negative Langerhans cell histiocytosis
Brown, N. A., Furtado, L. V., Betz, B. L., Kiel, M. J., Weigelin, H. C., Lim, M. S., & Elenitoba-Johnson, K. S. J. (2014) · Blood · doi:10.1182/blood-2014-05-577361 · Cited by 369
Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004
Guyot‐Goubin, A., Donadieu, J., Barkaoui, M., Bellec, S., Thomas, C., & Clavel, J. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21498 · Cited by 351
CENTRAL NERVOUS SYSTEM DISEASE IN LANGERHANS CELL HISTIOCYTOSIS
Grois, N. G., Favara, B. E., Mostbeck, G. H., & Prayer, D. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70511-6 · Cited by 347
Héritier, S., Emile, J.-F., Barkaoui, M.-A., Thomas, C., Fraitag, S., Boudjemaa, S., Renaud, F., Moreau, A., Peuchmaur, M., Chassagne-Clément, C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9508 · Cited by 342
Histiocytosis X histogenetic arguments for a Langerhans cell origin.
Nézelof, C., Basset, F., & Rousseau-Merck, M. F. (1973) · PubMed · Cited by 330
Allen, C. E., Li, L., Peters, T. L., Leung, H.-C. E., Yu, A., Man, T.-K., Gurusiddappa, S., Phillips, M. T., Hicks, M. J., Gaikwad, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902336 · Cited by 326
Self-citationHaroche, J., Cohen-Aubart, F., Emile, J.-F., Maksud, P., Drier, A., Tolédano, D., Barete, S., Charlotte, F., Cluzel, P., Donadieu, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1950 · Cited by 289
Association of langerhans cell histiocytosis with malignant neoplasms
Egeler, R. M., Neglia, J. P., Puccetti, D. M., Brennan, C. A., & Nesbit, M. E. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3<865::aid-cncr2820710334>3.0.co;2-0 · Cited by 281
BRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 275
How I treat Langerhans cell histiocytosis
Allen, C. E., Ladisch, S., & McClain, K. L. (2015) · Blood · doi:10.1182/blood-2014-12-569301 · Cited by 233
Self-citationIncidence of Langerhans cell histiocytosis in children: A population‐based study
Stålemark, H., Laurencikas, E., Karis, J., Gavhed, D., Fadeel, B., & Henter, J. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21504 · Cited by 225
Sahm, F., Capper, D., Preusser, M., Meyer, J., Stenzinger, A., Lasitschka, F., Berghoff, A.-S., Habel, A., Schneider, M., Kulozik, A., et al. (2012) · Blood · doi:10.1182/blood-2012-06-429597 · Cited by 221
Cohen Aubart, F., Emile, J.-F., Carrat, F., Charlotte, F., Benameur, N., Donadieu, J., Maksud, P., Idbaih, A., Barete, S., Hoang-Xuan, K., et al. (2017) · Blood · doi:10.1182/blood-2017-03-771873 · Cited by 212
Neuropathology of CNS disease in Langerhans cell histiocytosis
Grois, N. (2005) · Brain · doi:10.1093/brain/awh403 · Cited by 211
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
Mass, E., Jacome-Galarza, C. E., Blank, T., Lazarov, T., Durham, B. H., Ozkaya, N., Pastore, A., Schwabenland, M., Chung, Y. R., Rosenblum, M. K., et al. (2017) · Nature · doi:10.1038/nature23672 · Cited by 210 · cited 1×
“from the fetal yolk sac to drive neurodegeneration.(29)”
MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis
Nelson, D. S., van Halteren, A., Quispel, W. T., van den Bos, C., Bovée, J. V. M. G., Patel, B., Badalian‐Very, G., van Hummelen, P., Ducar, M., Lin, L., et al. (2015) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22247 · Cited by 202
Berres, M., Merad, M., & Allen, C. E. (2015) · British Journal of Haematology · doi:10.1111/bjh.13247 · Cited by 180
Self-citationAlternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Chakraborty, R., Burke, T. M., Hampton, O. A., Zinn, D. J., Lim, K. P. H., Abhyankar, H., Scull, B., Kumar, V., Kakkar, N., Wheeler, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-08-733790 · Cited by 172
Self-citationDonadieu, J., Bernard, F., van Noesel, M., Barkaoui, M., Bardet, O., Mura, R., Arico, M., Piguet, C., Gandemer, V., Armari Alla, C., et al. (2015) · Blood · doi:10.1182/blood-2015-03-635151 · Cited by 166
Satoh, T., Smith, A., Sarde, A., Lu, H., Mian, S., Trouillet, C., Mufti, G. J., Emile, J., Fraternali, F., Donadieu, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033891 · Cited by 166
Expansion of Regulatory T Cells in Patients with Langerhans Cell Histiocytosis
Sénéchal, B., Elain, G., Jeziorski, É., Grondin, V., Patey, N., Jaubert, F., Beldjord, K., Lellouch‐Tubiana, A., Glorion, C., Zérah, M., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040253 · Cited by 152
Langerhans-cell histiocytosis 'insight into DC biology'
Laman, J. D. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00063-2 · Cited by 147
Chikwava, K. R., & Jaffe, R. (2004) · Pediatric and Developmental Pathology · doi:10.1007/s10024-004-3027-z · Cited by 144
McClain, K. L., Picarsic, J. L., Chakraborty, R., Zinn, D., Lin, H., Abhyankar, H. A., Scull, B., Shih, A., Lim, K. P. H., Eckstein, O. S., et al. (2018) · Cancer · doi:10.1002/cncr.31348 · Cited by 137
Self-citationInflammation, Lymphatic Function, And Dendritic Cell Migration
Angeli, V., & Randolph, G. J. (2006) · Lymphatic Research and Biology · doi:10.1089/lrb.2006.4406 · Cited by 136
Hyman, D. M., Diamond, E. L., Vibat, C. R. T., Hassaine, L., Poole, J. C., Patel, M. A., Holley, V. R., Cabrilo, G., Lu, T. T., Arcila, M. E., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0742 · Cited by 134
Resistance to MEK inhibitors: should we co-target upstream?
Poulikakos, P. I., & Solit, D. B. (2011) · Science Signaling · doi:10.1126/scisignal.2001948 · Cited by 119
CONTROVERSIES AND NEW APPROACHES TO TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS
Arceci, R. J., Brenner, M. K., & Pritchard, J. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70514-1 · Cited by 118
Yeh, E. A., Greenberg, J., Abla, O., Longoni, G., Diamond, E. L., Hermiston, M. L., Tran, B. H., Galindo, C. R., Allen, C. E., & McClain, K. L. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26784 · Cited by 115
Self-citationLee, L. H., Gasilina, A., Roychoudhury, J., Clark, J. P., McCormack, F. X., Pressey, J. G., Grimley, M. S., Lorsbach, R. B., Ali, S. M., Bailey, M., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89473 · Cited by 101
van de Ven, R., van den Hout, M. F. C. M., Lindenberg, J. J., Sluijter, B. J. R., van Leeuwen, P. A. M., Lougheed, S. M., Meijer, S., van den Tol, M. P., Scheper, R. J., & de Gruijl, T. D. (2011) · Blood · doi:10.1182/blood-2011-03-344838 · Cited by 100
Allen, C. E., Flores, R. J., Rauch, R. A., Dauser, R., Murray, J. C., Puccetti, D., Hsu, D., Sondel, P. M., Hetherington, M. L., Goldman, S., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22326 · Cited by 96
Self-citationRecurrentNRASmutations in pulmonary Langerhans cell histiocytosis
Mourah, S., How‐Kit, A., Meignin, V., Gossot, D., Lorillon, G., Bugnet, E., Mauger, F., Lebbé, C., Chevret, S., Tost, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01677-2015 · Cited by 96
Circulating cell‐free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis
Héritier, S., Hélias‐Rodzewicz, Z., Lapillonne, H., Terrones, N., Garrigou, S., Normand, C., Barkaoui, M., Miron, J., Plat, G., Aladjidi, N., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14695 · Cited by 94
Hogstad, B., Berres, M., Chakraborty, R., Tang, J., Bigenwald, C., Serasinghe, M. N., Lim, K. P. H., Lin, H., Man, T., Remark, R., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161881 · Cited by 92
Self-citationDisseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1
Gatalica, Z., Bilalović, N., Palazzo, J., Bender, R. P., Swensen, J. J., Millis, S. Z., Vranić, S., Hoff, D. D. V., & Arceci, R. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4378 · Cited by 91
da Costa, C. E. T., Szuhai, K., van Eijk, R., Hoogeboom, M., Sciot, R., Mertens, F., Björgvinsdóttir, H., Dêbiec‐Rychter, M., de Krijger, R. R., Hogendoorn, P. C. W., et al. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20634 · Cited by 84
A phase II trial using thalidomide for Langerhans cell histiocytosis
McClain, K. L., & Kozinetz, C. A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20578 · Cited by 83
Self-citationNosology and Pathology of Langerhans Cell Histiocytosis
Picarsic, J. L., & Jaffe, R. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.001 · Cited by 80
Genomic Alterations in Langerhans Cell Histiocytosis
Rollins, B. J. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.004 · Cited by 73
Single-agent dabrafenib for BRAF V600E -mutated histiocytosis
Bhatia, A., Ulaner, G. A., Rampal, R. K., Hyman, D. M., Abdel-Wahab, O. I., Durham, B. H., Doǧan, A., Özkaya, N., Lacouture, M. E., Hajdenberg, J. J., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.185298 · Cited by 52
Neither IL-17A mRNA Nor IL-17A Protein Are Detectable in Langerhans Cell Histiocytosis Lesions
Peters, T., McClain, K. L., & Allen, C. E. (2011) · Molecular Therapy · doi:10.1038/mt.2011.106 · Cited by 35
Self-citationImashuku, S., & Arceci, R. J. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.006 · Cited by 21
Cited by
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Diamond, E. L., Durham, B. H., Ulaner, G. A., Drill, E., Buthorn, J., Ki, M., Bitner, L., Cho, H., Young, R. J., Francis, J. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1012-y · Cited by 395
The 2020 WHO Classification of Tumors of Bone: An Updated Review
Choi, J. H., & Ro, J. Y. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000293 · Cited by 395
Leader, A. M., Grout, J. A., Maier, B. B., Nabet, B. Y., Park, M. D., Tabachnikova, A., Chang, C., Walker, L., Lansky, A., Le Berichel, J., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.009 · Cited by 365
Self-citationRodriguez-Galindo, C., & Allen, C. E. (2020) · Blood · doi:10.1182/blood.2019000934 · Cited by 361
Self-citationDendritic cell subsets and locations
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.07.004 · Cited by 349
Metadata
- Authors
- Allen, C. E., Merad, M., & McClain, K. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-08-30
- Volume
- 379
- Issue
- 9
- Pages
- 856-868
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2587847258
- Cited by
- 570
- References
- 67
- FWCI
- 26.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.